Jennifer Kayden Lee's Net Worth
$2.83 Million
Who is Jennifer Kayden Lee?
Jennifer Kayden Lee has an estimated net worth of $2.83 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., and Krystal Biotech, Inc..
SEC CIK
Jennifer Kayden Lee's CIK is 0001801372
Past Insider Trading and Trends
2023 was Jennifer Kayden Lee's most active year for acquiring shares with 11 total transactions. Jennifer Kayden Lee's most active month to acquire stocks was the month of January. 2023 was Jennifer Kayden Lee's most active year for disposing of shares, totalling 21 transactions. Jennifer Kayden Lee's most active month to dispose stocks was the month of January. 2023 saw Jennifer Kayden Lee paying a total of $245,398.40 for 106,507 shares, this is the most they've acquired in one year. In 2024 Jennifer Kayden Lee cashed out on 46,862 shares for a total of $1,465,939.97, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
EVP, Head North America
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -72.69% | -18.23K |
$38.77 | -$707,004.96 | 6.85K |
Mar 20
| |||
Form 4
| -38.21% | -15.52K |
$39.22 | -$608,498.30 | 25.09K |
Mar 19
| |||
Form 4
| +492.56% | 33.75K |
—
|
—
| 40.6K |
Feb 16
| |||
Form 4
| +126.81% | 3.83K |
$50.80 | -$83,207.19 | 6.85K |
Feb 9 - Feb 13
| |||
Form 4
|
∞
| 3.02K |
$45.06 | -$67,229.52 | 3.02K |
Feb 1
| |||
Form 4
| -100.00% | -1.65K |
$19.40 | -$356,014.55 |
0
|
Scheduled
|
Nov 14
| ||
Form 4
|
—
|
0
|
$17.63 | -$198,067.45 | 1.65K |
Scheduled
|
Nov 8 - Nov 9
| ||
Form 4
|
—
|
0
|
$17.40 | -$1,696.00 | 1.65K |
Scheduled
|
Nov 3
| ||
Form 4
| -50.00% | -1.65K |
$17.43 | -$142,228.33 | 1.65K |
Sep 5
| |||
Form 4
| -44.41% | -2.63K |
$15.52 | -$243,612.13 | 3.29K |
Aug 7 - Aug 9
| |||
Form 4
| +39.39% | 1.4K |
$26.87 | -$17,062.45 | 4.94K |
Scheduled
|
Feb 11 - Feb 14
| ||
Form 4/A
| -25.36% | -1.20K |
$27.51 | -$33,122.04 | 3.54K |
Scheduled
|
Feb 9
| ||
Form 4
| +171.45% | 2.25K |
$27.66 | -$32,970.72 | 3.56K |
Scheduled
|
Feb 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 1.31K |
$6.10 | -$4,404.20 | 1.31K |
Scheduled
|
Feb 11 - Feb 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Krystal Biotech, Inc. (KRYS) Snapshot price: $184.19
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||